# The Future of Space Medicine

An episode of [Bedtime Astronomy](https://invisiblenetwork.ai/podcast/1736397134), 11 Jul 2026, 42 min.

Audio: https://dts.podtrac.com/redirect.mp3/api.spreaker.com/download/episode/72474875/medicp.mp3

Could future astronauts grow medicine instead of carrying it from Earth? This episode explores a new approach that turns plants into renewable pharmaceutical factories, allowing treatments to be produced on demand during long space missions. The technology could transform healthcare in space while opening new possibilities for low-cost medicine production on Earth. Thank you for listening to Bedtime Astronomy — your guide to the cosmos. New episodes on space exploration, NASA missions & the latest astronomy breakthroughs. This episode includes AI-generated content.

## Transcript

[0:03] Speaker 1: Welcome to Bedtime Astronomy. Explore the wonders of the cosmos
[0:07] Speaker 1: with our soothing Bedtime Astronomie podcast. Each episode offers a
[0:12] Speaker 1: gentle journey through the stars, planets, and beyond, perfect for
[0:16] Speaker 1: unwinding after a long day. Let's travel through the mysteries
[0:20] Speaker 1: of the universe. As you drift off into a peaceful
[0:22] Speaker 1: slumber under the night sky.
[0:26] Speaker 2: Think about the last time you stared at an old
[0:30] Speaker 2: bottle of antibiotics in your bathroom cabinet.
[0:33] Speaker 3: Oh yeah, checking that faded date stamped on the plastic.
[0:37] Speaker 2: Exactly, and you're just wondering, you know, is swallowing this
[0:40] Speaker 2: gold to cure me or it could quietly poison me?
[0:42] Speaker 1: Right?
[0:42] Speaker 3: And usually you probably just toss it in the trash
[0:44] Speaker 3: and drive down to the pharmacy to get a new one.
[0:46] Speaker 2: Yeah, but now I want you to imagine doing that
[0:48] Speaker 2: when the nearest pharmacy is one hundred and forty million
[0:52] Speaker 2: miles away.
[0:53] Speaker 3: That changes the math a bit, just a little.
[0:56] Speaker 2: Imagine you are packing your medical kid for a journey
[0:59] Speaker 2: that takes two hundred days just to reach the destination minimum, right, minimum,
[1:03] Speaker 2: And here is the terrifying mathematical reality of this trip. Yeah,
[1:08] Speaker 2: you know for an absolute fact that more than half
[1:10] Speaker 2: of your essential life saving medications in the cargo bay
[1:14] Speaker 2: are going to chemically expire before you even start the
[1:17] Speaker 2: journey home.
[1:17] Speaker 3: It's incredibly daunting.
[1:19] Speaker 2: It's a logistical nightmare. And this isn't some science fiction
[1:22] Speaker 2: thought experiment, you know, this is the very real, immediate
[1:25] Speaker 2: problem facing the engineers who are planning human missions to
[1:29] Speaker 2: Mars right now.
[1:30] Speaker 3: It really is, and it fundamentally changes the parameters of
[1:35] Speaker 3: how we view survival in space. How so, well, when
[1:38] Speaker 3: the public visualizes interplanetary travel, our collective imagination naturally gravitates
[1:44] Speaker 3: towards the massive hardware.
[1:45] Speaker 2: Oh sure, the giant rockets, the rovers exactly.
[1:48] Speaker 3: We picture the propulsion systems, the cryogenic rocket fuel, the
[1:52] Speaker 3: structural integrity of the pressure vessels, or the thermal shielding
[1:55] Speaker 3: gashi stuff. Right. The engineering marvels. But the biological challenge
[2:00] Speaker 3: of maintaining effective pharmacology in deep space is arguably a
[2:04] Speaker 3: much much harder problem to solve than the.
[2:06] Speaker 2: Propulsion, really harder than rocket science.
[2:09] Speaker 3: I mean, yeah, you can design the most advanced spacecraft
[2:12] Speaker 3: ever conceived, but if an astronaut develops a serious infection
[2:15] Speaker 3: on day four hundred of the mission and the only
[2:17] Speaker 3: broad spection antibiotics on board have chemically degraded into useless powder.
[2:22] Speaker 3: You lose the crew.
[2:23] Speaker 2: Wow.
[2:24] Speaker 3: Yeah, the hardware survives, but the mission fails.
[2:27] Speaker 2: That is wow. That is a dark thought. But today
[2:30] Speaker 2: we are zeroing in on a massive paradigm shift in
[2:34] Speaker 2: how we approach this exact problem.
[2:36] Speaker 3: And it's a fascinating shift, it really is.
[2:38] Speaker 2: We are looking at a breakthrough from engineers and pharmacologists
[2:42] Speaker 2: at the University of California, San Diego, and they aren't
[2:45] Speaker 2: trying to build a better pill bottle, No, not at all.
[2:49] Speaker 2: They are proposing we completely abandon the idea of bringing
[2:52] Speaker 2: finished pharmaceuticals into deep space altogether. Instead of packing thousands
[2:56] Speaker 2: of degrading pills, the proposal is to pack sea which
[3:00] Speaker 2: is just brilliant. Right. We're talking about turning plants into
[3:04] Speaker 2: reusable zero gravity biomanufacturing facilities.
[3:07] Speaker 3: And it's this beautiful pivot from pure chemistry back to biology.
[3:11] Speaker 3: It takes the intractable problem of chemical instability, of the
[3:14] Speaker 3: fact that complex molecules inherently want to break down over time,
[3:18] Speaker 3: and solves it with agriculture.
[3:20] Speaker 2: It's so elegant.
[3:21] Speaker 3: It is by synthesizing the disciplines of aerospace engineering, oncology,
[3:25] Speaker 3: and plant biology. The team at UC San Diego has
[3:28] Speaker 3: basically developed a method to grow, harvest, and purify vital
[3:32] Speaker 3: therapeutics right there in a spacecraft.
[3:35] Speaker 2: But the truly revolutionary aspect, and we'll get into this,
[3:38] Speaker 2: is that they have figured out how to extract the
[3:40] Speaker 2: medicine without destroying the plant, right.
[3:42] Speaker 3: And without requiring the massive, multi ton laboratory equipment you
[3:47] Speaker 3: would usually find in a terrestrial pharmaceutical plants.
[3:50] Speaker 2: Okay, let's back up a second and examine the timeline first,
[3:53] Speaker 2: because I want to understand why we can't just tough
[3:56] Speaker 2: it out with the current system. Sure, I mean, we
[3:58] Speaker 2: have astronauts living on the Internettional Space Station right now.
[4:01] Speaker 2: They get sick, they take medicine. Why is this suddenly
[4:05] Speaker 2: an insurmountable roadblock for Mars.
[4:07] Speaker 3: Well, the International Space Station is essentially orbiting in our
[4:10] Speaker 3: planetary suburbs, right It's close. It's only about two hundred
[4:13] Speaker 3: and fifty miles above us. So if a medical emergency happens,
[4:17] Speaker 3: or if supplies run low, we can just launch a
[4:20] Speaker 3: resupply capsule or just bring them home exactly in a
[4:23] Speaker 3: worst case scenario, we can bring the crew home in
[4:26] Speaker 3: a matter of hours. But even with that massive safety net,
[4:29] Speaker 3: the environment on the ISS provides a very stark warning.
[4:32] Speaker 2: What kind of warning?
[4:33] Speaker 3: Extensive research conducted on the medication stocks aboard the station
[4:37] Speaker 3: reviews are really sobering statistic. More than half of the
[4:40] Speaker 3: pharmaceuticals stored there expire within just three years.
[4:43] Speaker 2: Three years. See on Earth, three years sounds like a
[4:47] Speaker 2: completely reasonable shelf life for like an over the counter painkiller, right,
[4:51] Speaker 2: it seems fine, But let's apply that to orbital mechanics.
[4:55] Speaker 2: The timeline of a Mars mission makes a three year
[4:58] Speaker 2: window look like a flashing red warning light.
[5:00] Speaker 3: The margins are practically nonexistent. I mean, let's look at
[5:04] Speaker 3: the orbital mechanics of a home and transfer orbit, which
[5:07] Speaker 3: is basically the most fuel efficient path to Mars. You
[5:10] Speaker 3: are committing to roughly two hundred days of travel just
[5:14] Speaker 3: across the distance.
[5:15] Speaker 2: It's over six months in the vacuum of space.
[5:17] Speaker 3: Yes, but you can't just turn around and come right back.
[5:20] Speaker 3: You have to wait on the Martian's surface for the
[5:22] Speaker 3: planetary alignment to be correct for the return trip.
[5:25] Speaker 2: Because the planets are moving at different.
[5:26] Speaker 3: Speed exactly, and that weight can take well over a year.
[5:30] Speaker 3: Then you have another two hundred days in transit back
[5:33] Speaker 3: to Earth.
[5:33] Speaker 2: So you were looking at a minimum of two to
[5:36] Speaker 2: three years for the entire round trip minimum. Yeah, and
[5:39] Speaker 2: that three year expiration clock on the medication doesn't magically
[5:43] Speaker 2: start the second the rocket clears the launched out.
[5:45] Speaker 3: Oh, definitely not.
[5:46] Speaker 2: That clock starts the moment the active pharmaceutical ingredient is
[5:50] Speaker 2: synthesized and packaged in a factory in New Jersey or Switzerland.
[5:55] Speaker 3: Right, the chemical timer is already ticking.
[5:57] Speaker 2: By the time it clears quality control, getsransported to the
[6:00] Speaker 2: launch provider, sits in a payload, fearing for months, survives
[6:04] Speaker 2: the launch, and makes it all the way to Mars. Yeah,
[6:08] Speaker 2: your first aid kit is mostly full of degraded compounds.
[6:11] Speaker 3: And we really need to clarify what degraded actually means
[6:15] Speaker 3: in a biochemical context here.
[6:17] Speaker 2: Yeah, please do.
[6:18] Speaker 3: These drugs don't just become slightly less effective. The chemical
[6:22] Speaker 3: bonds of complex pharmaceuticals degrade much much faster in a
[6:27] Speaker 3: space environment than they do on Earth.
[6:29] Speaker 2: Because you are operating outside the protective bubble of Earth's atmosphere.
[6:34] Speaker 3: In our magnetosphere, yes.
[6:35] Speaker 2: I want to push back on that slightly, though, Why
[6:38] Speaker 2: is it so different? I mean, it's inside a climate
[6:40] Speaker 2: controlled spaceship. Sure, it's not like the astronauts are taping
[6:42] Speaker 2: their pill bottles to the outside of the hull. If
[6:45] Speaker 2: the temperature and humidity are perfectly controlled inside the ship,
[6:49] Speaker 2: why are the bonds breaking down faster than they would
[6:51] Speaker 2: in my kitchen.
[6:52] Speaker 3: Cabinet because of the radiation profile.
[6:55] Speaker 2: Uh, radiation.
[6:56] Speaker 3: Yeah, the ship's hull protects against a vacuum and extreme temperatures,
[7:00] Speaker 3: but it is highly porous to certain types of cosmic radiation.
[7:05] Speaker 3: Like what well, you have galactic cosmic rays, which are
[7:07] Speaker 3: these highly energetic particles originating from outside our solar system,
[7:11] Speaker 3: and you have solar proton events from the Sun exactly,
[7:15] Speaker 3: and these particles zip right through the aluminum hull of
[7:18] Speaker 3: the spacecraft and physically strike the medication.
[7:20] Speaker 2: Wow.
[7:22] Speaker 3: Yeah, When high energy radiation hits a complex organic molecule,
[7:26] Speaker 3: it causes ionization. It physically breaks the chemical bonds.
[7:30] Speaker 2: Ah, so it's a structural dismantling of the drug at
[7:33] Speaker 2: a molecular level. It's like leaving your medicine cabinet out
[7:36] Speaker 2: in the sun, but on a cosmic scale.
[7:38] Speaker 3: That's a great analogy, And the danger isn't just that
[7:41] Speaker 3: the drug loses its efficacy. In many cases, when those
[7:45] Speaker 3: specific molecular structures break down, they don't just become inert,
[7:48] Speaker 3: they become dangerous very They can degrade into toxic byproducts.
[7:53] Speaker 3: For example, certain degraded antibiotics like tetracycline can cause severe
[7:57] Speaker 3: kidney damage if ingested past their stability window. So taking
[8:01] Speaker 3: an expired drug in space isn't just a risk of
[8:04] Speaker 3: the drug not working. It's a very real risk of
[8:07] Speaker 3: active poisoning.
[8:08] Speaker 2: Okay, So the obvious engineering solution, and the one I
[8:11] Speaker 2: imagine most people immediately think of, is shielding. Right, if
[8:16] Speaker 2: radiation is the bullet killing the medicine, build a better
[8:20] Speaker 2: bulletproof vest, why aren't we just wrapping the medical bay
[8:24] Speaker 2: in thick layers of lead, or engineering the chemical formulas
[8:27] Speaker 2: to be more robust.
[8:28] Speaker 3: Well, Altering the chemistry of a highly specific pharmaceutical is
[8:32] Speaker 3: incredibly dangerous. The active ingredients rely on a precise locking
[8:36] Speaker 3: key mechanism to interact with the cellular receptors in the
[8:39] Speaker 3: human body.
[8:40] Speaker 2: So you can't just change the shape of the key exactly.
[8:43] Speaker 3: If you attempt to alter the molecular formulation to make
[8:45] Speaker 3: it radiation hardened, you invariably change how it interacts with
[8:49] Speaker 3: human biology. It might fail to bind to the target receptor.
[8:52] Speaker 2: Entirely, making it useless anyway.
[8:54] Speaker 3: Right, And as for physical shielding, that runs headfirst into
[8:57] Speaker 3: the tyrant of spaceflight, the Silkovski rocket.
[9:00] Speaker 2: Equation ah the mass penalty.
[9:01] Speaker 3: Exactly the issue. Every single gram of payload you want
[9:05] Speaker 3: to push out of Earth's gravity well requires an exponential amount.
[9:09] Speaker 2: Of rocket fuel, and lead is heavy.
[9:12] Speaker 3: Incredibly dense and heavy. If you surround your medicine cabinet
[9:16] Speaker 3: with an inch of lead to block the radiation, you
[9:19] Speaker 3: are adding hundreds of pounds to.
[9:21] Speaker 2: The spacecraft, which means more fuel.
[9:23] Speaker 1: Right.
[9:23] Speaker 3: To lift those hundreds of pounds, you need thousands of
[9:27] Speaker 3: pounds of extra propellant, which means you need bigger fuel tanks,
[9:31] Speaker 3: which add more mass, requiring even more fuel.
[9:34] Speaker 2: It's a vicious cycle.
[9:36] Speaker 3: The economics and physics of rocket launches simply do not
[9:38] Speaker 3: allow you to heavily shield cargo unless it is absolutely critical,
[9:42] Speaker 3: like the actual crew quarters.
[9:44] Speaker 2: So we're trapped. We can't bring enough medicine because it expires.
[9:48] Speaker 2: We can't shield it because of the rocket equation. We
[9:51] Speaker 2: can't change the chemistry without ruining the drug exactly. The
[9:54] Speaker 2: only logical path forward is abandoning the concept of a
[9:57] Speaker 2: pre packed pharmacy entirely. We have to ma manufactured the
[10:00] Speaker 2: drugs on demand locally in transit.
[10:03] Speaker 3: That's the only viable option.
[10:05] Speaker 2: But how do you put a pharmaceutical factory on a spaceship?
[10:08] Speaker 2: I mean, we're talking about trading massive stainless steel chemical
[10:12] Speaker 2: vats for a greenhouse.
[10:14] Speaker 3: The concept of biomanufacturing is the key here. Terrestrial pharmaceutical
[10:19] Speaker 3: manufacturing is the definition of heavy resource intensive industry.
[10:23] Speaker 2: Oh absolutely.
[10:24] Speaker 3: If you look at how synthetic drugs or complex biologics
[10:27] Speaker 3: are made on Earth, it involves massive bioreactors, intricate piping
[10:32] Speaker 3: networks for chemical precursors, extreme sterilization protocols.
[10:37] Speaker 2: And massive clean rooms to prevent contamination. You cannot shrink
[10:41] Speaker 2: a Pfizer or Maderna manufacturing plant and bolt it into
[10:44] Speaker 2: the corner of a cramped Mars transit habitat.
[10:46] Speaker 3: It's physically impossible, but nature has already spent millions of
[10:50] Speaker 3: years perfecting a highly efficient miniaturized self assembling manufacturing plant.
[10:54] Speaker 2: A seed yes, and that is a seed.
[10:57] Speaker 3: When you look at a seed, you are looking at
[10:58] Speaker 3: an incredibly dense packet of genetic information.
[11:01] Speaker 2: It's like a zip file of biology.
[11:03] Speaker 3: That's a perfect way to describe it. It contains the
[11:06] Speaker 3: complete biological blueprint to construct a complex physical structure capable
[11:10] Speaker 3: of synthesizing highly complex therapeutic compounds utilizing only ambient light, water,
[11:16] Speaker 3: and atmospheric gases.
[11:18] Speaker 2: That is a brilliant way to reframe it. We usually
[11:20] Speaker 2: think of plants as food or decoration, but fundamentally they
[11:24] Speaker 2: are programmable chemical factories. And you can hold a thousand
[11:28] Speaker 2: of these factories in the palm of your hand. A
[11:30] Speaker 2: packet of seeds weighs a few grams, the mass penalty
[11:33] Speaker 2: is effectively zero.
[11:35] Speaker 3: Furthermore, integrating agriculture into a spacecraft architecture solves multiple problems simultaneously.
[11:41] Speaker 2: Oh the dual purpose aspect. Yes.
[11:43] Speaker 3: In systems engineering, especially in aerospace, there is a core
[11:46] Speaker 3: principle that every single component should.
[11:48] Speaker 2: Serve multiple functions, right, no dead wight.
[11:50] Speaker 3: Exactly. If you bring a massive steel bier reactor to
[11:53] Speaker 3: make drugs, it just sits there, taking up volume and
[11:56] Speaker 3: drawing power until someone gets sick. It has a single
[11:59] Speaker 3: sparade that.
[12:00] Speaker 2: A plant is part of the life support.
[12:02] Speaker 3: Loop precisely as the plants grow, even before they are
[12:06] Speaker 3: needed to produce medicine, they are actively contributing to the
[12:09] Speaker 3: environmental control and life support system of.
[12:12] Speaker 2: The spacecraft, so they're working full time.
[12:14] Speaker 3: They are absorbing the carbon dioxide exhaled by the crew.
[12:18] Speaker 3: They are undergoing photosynthesis to release pure oxygen and water.
[12:23] Speaker 3: Yes through transpiration, they are releasing moisture into the air,
[12:27] Speaker 3: which can then be condensed and recycled into the ship's
[12:30] Speaker 3: drink and water supply.
[12:32] Speaker 2: So what does this all mean. We are essentially trading
[12:34] Speaker 2: a massive industrial chemical plant for a high tech greenhouse.
[12:39] Speaker 2: They are essentially biological scrubberd.
[12:41] Speaker 3: It's a closed loop ecosystem.
[12:43] Speaker 2: You are integrating your pharmaceutical supply chain directly into your
[12:47] Speaker 2: air and water recycling systems. It makes perfect sense for
[12:50] Speaker 2: deep space survival.
[12:51] Speaker 3: It's incredibly elegant.
[12:53] Speaker 2: But I have to ask about the reality of what
[12:55] Speaker 2: we can actually grow. We aren't talking about growing a
[12:58] Speaker 2: nice patch of aloverara for a space burn, or brewing
[13:01] Speaker 2: willowbar t for a headache.
[13:03] Speaker 3: No, not at all.
[13:03] Speaker 2: The actual compound. The UC San Dieo team tested is
[13:07] Speaker 2: where the biology takes a very unexpected turn.
[13:09] Speaker 3: Yes, the demonstration focused on an experimental therapeutic compound that
[13:14] Speaker 3: the study's senior author, Nicole Steinmetz, alongside our colleagues, has
[13:18] Speaker 3: been developing and analyzing for more than a decade.
[13:21] Speaker 2: And it's not a simple drug.
[13:22] Speaker 3: They didn't choose a simple painkiller. No, they chose a
[13:25] Speaker 3: highly complex biologic derived from a plant virus. It is
[13:29] Speaker 3: known as the cowp mosaic virus or CPMV.
[13:33] Speaker 2: Hold on, they're trying to manufacture life saving astronaut medicine
[13:38] Speaker 2: and the blueprint they are using is a virus that
[13:41] Speaker 2: naturally infects ligomes. I know, it's it sounds completely counterintuitive.
[13:45] Speaker 2: Why are we bringing plant diseases into a closed spacecraft ecosystem?
[13:49] Speaker 3: It sounds alarming. I agree, But the mechanics of this
[13:52] Speaker 3: specific virus are exactly what makes it so valuable. Okay,
[13:55] Speaker 3: explain that CPMV naturally infects plants like black eyed peas,
[13:59] Speaker 3: hence the cowpe in the name. When it infects the plant,
[14:02] Speaker 3: it creates these distinct mosaic like yellow and green patterns
[14:07] Speaker 3: on the.
[14:07] Speaker 2: Leaves because it's hijacking the plant.
[14:09] Speaker 3: Right as it hijacks the plant's cellular machinery to replicate itself.
[14:12] Speaker 3: But researchers aren't interested in the virus for its effect
[14:15] Speaker 3: on plants. They are interested in what happens when this
[14:18] Speaker 3: exact viral structure is introduced into a mammalian body.
[14:22] Speaker 2: Well, the obvious question is if an astronaut handles this
[14:25] Speaker 2: or gets it in their bloodstream, does it infect them?
[14:29] Speaker 3: No, and that is a crucial distinction. Plant viruses do
[14:32] Speaker 3: not have the necessary molecular keys to enter and hijack
[14:36] Speaker 3: human or mammalian.
[14:37] Speaker 2: Cells, so we are immune to it.
[14:39] Speaker 3: We are entirely immune to CPMV in the sense of
[14:42] Speaker 3: an infectious disease. It cannot replicate inside an astronaut.
[14:45] Speaker 2: Okay, that's a relief.
[14:46] Speaker 3: However, the physical structure of the virus, the geometric protein
[14:50] Speaker 3: shell known as the capsid, acts as an incredibly potent
[14:53] Speaker 3: alarm bell for the mammalian immune system.
[14:55] Speaker 2: Like waving a massive red flag in front of the
[14:58] Speaker 2: body's defense forces.
[14:59] Speaker 3: Exactly. The human immune system is highly attuned to recognizing
[15:03] Speaker 3: specific molecular patterns associated with pathogens.
[15:06] Speaker 2: It sees a virus shape and attacks right.
[15:08] Speaker 3: When CPMV is injected into a mammal. The immune system
[15:11] Speaker 3: immediately recognizes this foreign, highly structured protein shell. It registers
[15:17] Speaker 3: as a massive threat, even though it cannot.
[15:19] Speaker 2: Replicate, so the body freaks out.
[15:21] Speaker 3: It triggers a localized, highly aggressive immune response, and researchers
[15:26] Speaker 3: have webonized this response to target cancer.
[15:29] Speaker 2: Let me see if I follow the logic here, here's
[15:31] Speaker 2: where it gets really interesting. Cancer is incredibly difficult to
[15:35] Speaker 2: fight because it's essentially our own cells mutating. Yes, the
[15:39] Speaker 2: immune system often ignores tumors because they don't look like
[15:43] Speaker 2: foreign invaders. The body thinks the tumor belongs there.
[15:46] Speaker 3: That is the core challenge of oncology. We refer to
[15:49] Speaker 3: these as cold tumors. They are metabolically active, but they
[15:53] Speaker 3: are practically invisible to the immune.
[15:55] Speaker 2: System because they're hiding in plain sight.
[15:57] Speaker 3: They actively suppress the body's natural killer T cells from
[16:01] Speaker 3: entering the tumor micro environment.
[16:02] Speaker 2: But if you inject this plant virus directly into that
[16:05] Speaker 2: cold tumor, you flip the switch. Wow.
[16:07] Speaker 3: The introduction of CPMV changes the tumor micro environment from
[16:11] Speaker 3: cold to hot. The immune system detects the plant virus
[16:14] Speaker 3: inside the tumor and mounts a massive, aggressive.
[16:17] Speaker 2: Infiltration, so the T cells Russian.
[16:19] Speaker 3: The T cells rush in to destroy the viral threat.
[16:22] Speaker 3: But in the chaos of clearing out the plant virus,
[16:25] Speaker 3: the immune system finally sees the surrounding cancer cells.
[16:29] Speaker 2: The cloaking mechanism is broken.
[16:30] Speaker 3: The immune system attacks the virus and then just proceeds
[16:33] Speaker 3: to eradicate the tumor cells as well.
[16:36] Speaker 2: That is staggering. We are taking a virus that makes
[16:38] Speaker 2: PAS sick and using it to trigger an immune response
[16:42] Speaker 2: to fight cancer in dogs and mice. You are essentially
[16:46] Speaker 2: using a harmless agricultural virus as a biological targeting laser.
[16:50] Speaker 3: The clinical data backs up the sheer potency of this approach.
[16:53] Speaker 3: The research highlights that CPMV has demonstrated remarkable anti tumor
[16:58] Speaker 3: efficacy in preclinical mousemare models.
[17:00] Speaker 2: That's incredible.
[17:01] Speaker 3: Even more compelling, it has shown highly positive effects in
[17:04] Speaker 3: actual clinical trials involving canine cancer patients. We are talking
[17:08] Speaker 3: about a highly complex, highly effective immunotherapeutic here.
[17:12] Speaker 2: And to manufacture this complex biologic the engineers utilize specific
[17:16] Speaker 2: host plants as the bioreactors.
[17:17] Speaker 3: Yes exactly.
[17:19] Speaker 2: I noticed they use black eyed pea plants, which makes
[17:22] Speaker 2: sense given the virus, but they also rely heavily on
[17:25] Speaker 2: a plant called Nikotiana pin thumiana. Why choose these specific
[17:29] Speaker 2: plants instead of something heartier like potatoes or wheat.
[17:32] Speaker 3: The selection of Nikotiana bin thumiana is not accidental at all.
[17:37] Speaker 3: In the field of plant biology and biomanufacturing. It is
[17:40] Speaker 3: essentially the equivalent of the laboratory mouse. Really, how so
[17:44] Speaker 3: it has been extensively utilized because of a unique genetic quirk.
[17:48] Speaker 3: It has a naturally compromised anti viral defense system.
[17:52] Speaker 2: Wait, really, they specifically chose a plant with a weak
[17:55] Speaker 2: immune system.
[17:55] Speaker 3: Yes, if you want a plant to produce massive quantities
[17:58] Speaker 3: of a virus, you don't want the plant fighting back.
[18:00] Speaker 2: Oh, that makes perfect sense.
[18:02] Speaker 3: Yakochianabnthemiana allows the CPMV vector to replicate at an astonishing rate.
[18:07] Speaker 3: The study's first author, Patrick Oppenstein and emphasizes that growing
[18:10] Speaker 3: the therapeutic compound within these plants is actually the simplest
[18:14] Speaker 3: part of the.
[18:14] Speaker 2: Entire equation because they grow fast.
[18:16] Speaker 3: The plants grow incredibly fast, producing a massive amount of
[18:20] Speaker 3: leafy biomass in just weeks.
[18:22] Speaker 2: So the math is simple. Greater biomass in less time
[18:26] Speaker 2: equals a higher yield of the pharmaceutical product. You plant
[18:30] Speaker 2: the seed, you wait a few weeks for it to
[18:31] Speaker 2: grow leaves, You introduce the CPMV virus, and suddenly your
[18:35] Speaker 2: plant is churning out millions of cancer fighting viral capsids.
[18:39] Speaker 3: It's remarkably efficient.
[18:40] Speaker 2: It sounds like a completely solved problem.
[18:42] Speaker 3: It would be if getting the medicine out of the
[18:45] Speaker 3: plant was as easy as growing it.
[18:46] Speaker 2: Ah, there's the catch.
[18:48] Speaker 3: This is where the entire concept of space based biomanufacturing
[18:52] Speaker 3: usually hits an impenetrable wall. The actual growth of the
[18:55] Speaker 3: plant is trivial compared to the downstream processing, so the
[18:59] Speaker 3: bottleneck is ex The real bottleneck is extraction. Walk me
[19:02] Speaker 3: through the traditional extraction method on Earth. If a pharmaceutical
[19:06] Speaker 3: company is growing plant based drugs right now, how are
[19:09] Speaker 3: they getting the medicine out of the leaves? The traditional
[19:12] Speaker 3: methodology is, at its core remarkably brute force. The standard
[19:17] Speaker 3: protocol involves harvesting the plant, physically stripping the leaves, placing
[19:21] Speaker 3: them into massive industrial homogenizers, and grinding them into a pulp.
[19:26] Speaker 2: They literally make a plant smoothie, a.
[19:28] Speaker 3: Very thick, highly complex biological smoothie. You are applying immense
[19:34] Speaker 3: mechanical sheer force to obliterate the cellular structure of the leaf,
[19:38] Speaker 3: just rooping it apart, ripping apart the cell walls, the
[19:41] Speaker 3: plasma membranes, the chloroplasts. You end up with this sledgy
[19:45] Speaker 3: green puree consisting of cellulose, chlorophyll, complex plant proteins, and
[19:52] Speaker 3: intracellular fluids.
[19:54] Speaker 2: And trapped somewhere inside that massive volume of green sludge
[19:58] Speaker 2: are the microscopic seat PMV viral capsids you actually need
[20:02] Speaker 2: for the medicine.
[20:02] Speaker 3: Yes, and locating and isolating those specific nanoparticles from that
[20:07] Speaker 3: chaotic biological soup is a chemical engineering nightmare.
[20:11] Speaker 2: I can imagine.
[20:12] Speaker 3: Chlorophyll in particular is notoriously difficult to separate from therapeutic
[20:15] Speaker 3: proteins to purify the medicine. Terrestrial labs rely on massive
[20:19] Speaker 3: equipment like what you need industrial scale centrifuges, and I
[20:22] Speaker 3: do not mean the small tabletop models. These are massive,
[20:25] Speaker 3: high G force machines designed to separate liquids by density
[20:28] Speaker 3: over several hours.
[20:29] Speaker 2: Wow.
[20:30] Speaker 3: After that, the liquid must be pushed through complex chromatography
[20:33] Speaker 3: columns in multiple stages of chemical filtration, which brings.
[20:36] Speaker 2: Us right back to the mass penalty. We talked about earlier.
[20:38] Speaker 2: You can't exactly strap a giant industrial centrifuge in chemical
[20:42] Speaker 2: separation lab onto a rocket.
[20:44] Speaker 3: You really can't. Patrick Oppenstein notes in the research that
[20:48] Speaker 3: the equipment required for this standard extraction process fills their
[20:52] Speaker 3: entire laboratory.
[20:54] Speaker 2: That's just the non starter for space completely.
[20:57] Speaker 3: If you have an astronaut floating in a habitation module,
[21:00] Speaker 3: they cannot deal with a minivan sized industrial centrifuge and
[21:04] Speaker 3: a series of pressurized chromatography columns.
[21:07] Speaker 2: It completely defeats the original purpose. The entire theoretical advantage
[21:11] Speaker 2: of bringing seeds was to eliminate the weight in space
[21:14] Speaker 2: required for heavy machinery.
[21:16] Speaker 3: Exactly.
[21:17] Speaker 2: If the extraction process forces you to bring a literal
[21:20] Speaker 2: ton of homogenization and clarification equipment just to process the leaves,
[21:24] Speaker 2: you're actually worse off than if you just brought the
[21:26] Speaker 2: lead shielded pills.
[21:27] Speaker 3: It's an absurd visual, honestly.
[21:29] Speaker 2: It really is. Imagine needing a pristine, sterile medical injection
[21:33] Speaker 2: and the astronaut is wrestling with a blender full of
[21:36] Speaker 2: green mush trying to squeeze out a single, perfectly clean
[21:39] Speaker 2: drop of water from a blended green smoothie.
[21:42] Speaker 3: It's messy, wasteful, and requires far too much heavy machinery.
[21:47] Speaker 2: You destroy the entire plant factory just to get a
[21:49] Speaker 2: tiny yield. Astronauts need a pristine pharmacy, but traditional plant
[21:55] Speaker 2: extraction gives you a messy kitchen blender.
[21:57] Speaker 3: Therefore, the UC San Diego team recognize that to make
[22:00] Speaker 3: space based biomanufacturing a reality, they had to entirely reinvent
[22:05] Speaker 3: the physics of extraction. To start from scratch, they needed
[22:08] Speaker 3: a method that bypassed the homogenization bottleneck entirely. They needed
[22:13] Speaker 3: a way to convince the plant to surrender the therapeutic
[22:15] Speaker 3: compound without destroying the structural integrity of the leaf itself.
[22:19] Speaker 2: And this is where the research shifts from standard agriculture
[22:23] Speaker 2: to what looks like well microscopic hacking.
[22:25] Speaker 3: It really does.
[22:26] Speaker 2: They figured out a way to extract the medicine without
[22:29] Speaker 2: breaking a single cell, and they did it by exploiting
[22:31] Speaker 2: a specific anatomical feature of the leaf called the appolplast.
[22:35] Speaker 3: It is a masterful piece of biological leverage. To understand
[22:39] Speaker 3: why this works, we must briefly look at how mammalian
[22:42] Speaker 3: cells function in standard bioreactors. In those multimillion dollar terrestrial vats.
[22:47] Speaker 3: The engineered cells often naturally secrete the therapeutic proteins.
[22:51] Speaker 2: They just push it out right.
[22:53] Speaker 3: The cells manufacture the drug and push it out through
[22:55] Speaker 3: their cell membranes into the surrounding liquid broth, where it
[22:59] Speaker 3: can be continuously collected without killing the cell.
[23:02] Speaker 2: So the researchers looked at that process and wondered, can
[23:06] Speaker 2: we force a plant leaf to mimic that secretion process?
[23:09] Speaker 3: Yes, and the secret lies in the microscopic architecture of
[23:13] Speaker 3: a leaf. We tend to visualize a leaf as a
[23:17] Speaker 3: solid sheet of green tissue right, like a flat solar panel,
[23:20] Speaker 3: but it is actually highly porous. Inside the leaf, you
[23:24] Speaker 3: have individual plant cells, each enclosed by a rigid cell
[23:27] Speaker 3: wall and a plasma membrane. Okay, However, between these individual cells,
[23:31] Speaker 3: outside the plasma membranes, there is a vast interconnected network
[23:36] Speaker 3: of empty spaces and microscopic channels.
[23:38] Speaker 2: It's like a network of subterranean caves running through the
[23:41] Speaker 2: entire leaf.
[23:42] Speaker 3: That network of extracellular space is called the epoplast. And
[23:45] Speaker 3: what the research team verified is that when the plant
[23:47] Speaker 3: cells are infected with the CPMV virus and begin manufacturing
[23:51] Speaker 3: the viral capsids. They do not just hoard them inside
[23:54] Speaker 3: the cell. The plant actually secretes a massive volume of
[23:58] Speaker 3: these viral nanoparticles out through the plasma membrane and directly
[24:02] Speaker 3: into the interconnected channels of the apoplast.
[24:05] Speaker 2: So the medicine isn't locked inside the tough cellular vaults.
[24:08] Speaker 2: It's just sitting out in the open hallways of the
[24:11] Speaker 2: leaf structure, completely isolated from the messy chlorophyll and cellular.
[24:15] Speaker 3: Organelsias already separated.
[24:17] Speaker 2: If the medicine is already sitting in those empty spaces,
[24:20] Speaker 2: you don't need a blender. You don't need to destroy
[24:22] Speaker 2: the cells. You just need to figure out a way
[24:24] Speaker 2: to flesh out the hallways.
[24:25] Speaker 3: And the mechanical process they engineered to flush the apoplast
[24:28] Speaker 3: is brilliantly streamlined. It requires absolutely no heavy machinery.
[24:32] Speaker 2: Walking through it. Let's trace the exact steps.
[24:34] Speaker 3: First, the astronaut takes the intact living leaves, no cutting,
[24:38] Speaker 3: no grinding, and submerges them entirely in a specific liquid
[24:42] Speaker 3: buffer solution inside a small sealed container.
[24:45] Speaker 2: Drown the intact leaf in a closed jar. Got it.
[24:48] Speaker 3: The second step relies on fluid dynamics and pressure differentials.
[24:52] Speaker 3: The astronaut applies a vacuum to that sealed container.
[24:55] Speaker 2: Okay, what does the vacuum do now?
[24:57] Speaker 3: Because the leaf is porous, vacuum physically pulls the ambient
[25:02] Speaker 3: air right out of the apoplast spaces. The microscopic hallways
[25:06] Speaker 3: are suddenly empty of gas.
[25:08] Speaker 2: Oh, I see where this is going.
[25:09] Speaker 3: As soon as the vacuum pressure is normalized, the liquid
[25:12] Speaker 3: buffer solution immediately rushes in to fill the void left
[25:16] Speaker 3: by the air.
[25:16] Speaker 2: It's forced infiltration. The liquid is practically shoved into the
[25:20] Speaker 2: internal structure of the leaf by the pressure change. Exactly so,
[25:24] Speaker 2: now instead of being full of air, all those tiny
[25:27] Speaker 2: apoplastic channels are flooded with the liquid buffer. The medicine
[25:31] Speaker 2: the CPMB particles are now suspended in that liquid inside the.
[25:35] Speaker 3: Leaf, precisely. Step three is the actual extraction. The astronaut
[25:39] Speaker 3: takes these water logged intact leaves, places them into specialized vials,
[25:43] Speaker 3: and loads them into a centrifuge.
[25:45] Speaker 2: But not the massive industrial one, right.
[25:47] Speaker 3: No, here is the critical difference. This is a small,
[25:50] Speaker 3: lightweight device and it only applies a very gentle rotational force.
[25:54] Speaker 2: Just enough centrifugal gravity to pull the heavy liquid down.
[25:57] Speaker 2: But not enough force to actually rupture the plant sells themselves.
[26:01] Speaker 3: The physics are beautifully balanced. The gentle spinning forces the fluid,
[26:05] Speaker 3: which has now captured the therapeutic viral particles, to be
[26:08] Speaker 3: drawn right back out.
[26:09] Speaker 2: Of the stomata the pores of the leaf.
[26:11] Speaker 3: Right the liquid exits the apoplast exactly the way it
[26:14] Speaker 3: came in. Finally, the astronaut takes that extracted fluid and
[26:18] Speaker 3: passes it through a simple lightweight filter to catch any
[26:21] Speaker 3: microscopic bits of dust or surface material.
[26:24] Speaker 2: And that's it. You have purified medicine. I love this.
[26:27] Speaker 2: It's like ringing out a microscopic sponge without damaging the
[26:31] Speaker 2: sponge itself.
[26:32] Speaker 3: That's the perfect analogy. And the preservation of the leaf
[26:35] Speaker 3: structure is the true breakthrough.
[26:36] Speaker 2: Here because it's still alive.
[26:38] Speaker 3: Because the leaf is never mechanically homogenized, the plant remains
[26:42] Speaker 3: biologically viable. The astronaut can perform this vacuum infiltration and
[26:46] Speaker 3: extraction process, harvest the medicine, and potentially leave the plant
[26:50] Speaker 3: alive to continue growing and producing more medicine.
[26:53] Speaker 2: It fundamentally rewrites the resource math of a deep space mission.
[26:58] Speaker 2: You are no longer destroying your entire factctory to get
[27:00] Speaker 2: one batch of pills.
[27:01] Speaker 3: No, you get continuous returns.
[27:03] Speaker 2: A single seed utilizing ambient ship carbon dioxide and recycled
[27:08] Speaker 2: water can yield multiple continuous harvests of a highly complex aminotherapeutic.
[27:13] Speaker 2: And this speed is staggering.
[27:15] Speaker 3: It really is.
[27:16] Speaker 2: The researchers demonstrated they could process over fifty plants and
[27:19] Speaker 2: secure purified medicine in less than two hours.
[27:22] Speaker 3: And the vision extends even further. Their long term engineering
[27:25] Speaker 3: goal is to eliminate the need to pluck leaves at all.
[27:28] Speaker 2: Really, how would they do that?
[27:30] Speaker 3: They are working toward adapting this vacuum infiltration system to
[27:33] Speaker 3: encompass whole living potted plants. The theoretical workflow involves placing
[27:39] Speaker 3: an entire living plant into a small vacuum chamber, flushing
[27:43] Speaker 3: the root to leaf apoplastic.
[27:44] Speaker 2: Network, extracting the medicine, and putting the pot back into
[27:47] Speaker 2: the grow like exactly.
[27:49] Speaker 3: It is a fully sustainable, closed loop biomanufacturing ecosystem.
[27:53] Speaker 2: It is an incredible solution on paper, but I see
[27:56] Speaker 2: a massive gap between doing this in a pristine laboratory
[27:59] Speaker 2: in southern caliph and executing it aboard a spacecraft hurtling
[28:03] Speaker 2: toward Mars.
[28:03] Speaker 3: Oh.
[28:04] Speaker 2: Absolutely. The physics, we just describe the way the Bucker
[28:07] Speaker 2: solution infiltrates the leaf, the way the fluid drains out
[28:10] Speaker 2: during centrification. All of that relies on fluid dynamics that
[28:14] Speaker 2: evolved entirely under the constant pull of Earth's gravity.
[28:18] Speaker 3: That's a huge variable.
[28:20] Speaker 2: When you remove gravity, fluids behave bizarrely, surface tension takes
[28:25] Speaker 2: over water, creeps up walls. You can't just assume this
[28:28] Speaker 2: delicate internal leaf flushing will work in microgravity.
[28:31] Speaker 3: That is the exact skepticism the engineering team shared. Validating
[28:35] Speaker 3: a biological process on Earth is meaningless for aerospace applications
[28:39] Speaker 3: unless you can prove it survives the environmental extremes of orbit.
[28:44] Speaker 3: They had to simulate the reality of spaceflight to achieve this.
[28:47] Speaker 3: Nicolstein Metz's pharmacology lab initiated a cross disciplinary partnership with
[28:52] Speaker 3: Masir Gazinajad, who is that He's a professor of Mechanical
[28:56] Speaker 3: and aerospace engineering at UC San Diego and his lab
[28:59] Speaker 3: focuses on matil curial's behavior in extreme environments.
[29:02] Speaker 2: So the plant biologists bring in the orbital mechanics experts
[29:05] Speaker 2: to try and break the system exactly.
[29:07] Speaker 3: They needed to introduce two major variables, microgravity and cosmic radiation.
[29:12] Speaker 3: To simulate microgravity, the aerospace team utilized a custom engineered
[29:17] Speaker 3: device known as a random positioning machine.
[29:20] Speaker 2: I am fascinated by the mechanics of this. Yeah, how
[29:22] Speaker 2: does a machine sitting on a lab bench in California
[29:26] Speaker 2: actually simulate the absence of gravity? You can't turn off
[29:30] Speaker 2: Earth's mass.
[29:31] Speaker 3: You cannot negate gravity, no, but you can continuously confuse
[29:34] Speaker 3: the biological systems attempting to sense it. Interesting, A random
[29:38] Speaker 3: positioning machine, often utilizing Klanistat principles, places the biological sample
[29:43] Speaker 3: in the center of a complex gimbal apparatus. This gimbal
[29:46] Speaker 3: continuously rotates the plant in three dimensional space along multiple
[29:51] Speaker 3: axis simultaneously at constantly varying randomized speeds.
[29:55] Speaker 2: It sounds like an aggressive gyroscope.
[29:57] Speaker 3: It really is. Plants have highly evolved mechanism for sensing gravity,
[30:01] Speaker 3: primarily utilizing specialized cells containing dense starch granules called statolith. Yes,
[30:07] Speaker 3: in normal gravity, these granules settle to the bottom of
[30:09] Speaker 3: the cell, telling the plant which way is down, so
[30:11] Speaker 3: the roots snow where to grow. Makes sense, But when
[30:14] Speaker 3: you place the plant in a random positioning machine, the
[30:17] Speaker 3: directional vector of gravity is constantly changing. Before the statoliths
[30:22] Speaker 3: have time to settle and signal down, the plant is
[30:25] Speaker 3: flipped sideways, then inverted, then spun.
[30:28] Speaker 2: The plant is biologically disoriented. The mechanical rotation essentially averages
[30:33] Speaker 2: out the gravitational pull to zero across all three axes.
[30:37] Speaker 2: Over time, exactly from the cellular perspective of the leaf,
[30:40] Speaker 2: gravity has effectively ceased to exist.
[30:43] Speaker 3: The simulation is highly effective at mimicking the physiological stress
[30:46] Speaker 3: of microgravity. But orbit is not just weightless, it is
[30:50] Speaker 3: toxic the radiation. To simulate the damage caused by the
[30:53] Speaker 3: galactocosmic rays and solar proton events we discussed earlier, the
[30:57] Speaker 3: engineering teams subjected these tumbling plants to extreme temperature fluctuations
[31:02] Speaker 3: and severe oxidative stress.
[31:04] Speaker 2: Walk me through oxidative stress. What are they actually doing
[31:07] Speaker 2: to the plant to mimic radiation.
[31:08] Speaker 3: When high energy radiation strikes biological tissue, it creates reactive
[31:12] Speaker 3: oxygen species or free radicals.
[31:15] Speaker 2: Those are bad news, very bad.
[31:17] Speaker 3: These are highly unstable molecules that aggressively strip electrons from
[31:21] Speaker 3: cellular membranes and DNA, causing massive cellular damage.
[31:26] Speaker 2: So how do they mimic that.
[31:28] Speaker 3: The researchers chemically induced this exact type of biochemical damage
[31:32] Speaker 3: in the plants. They were intentionally trying to push the
[31:35] Speaker 3: biological factory to the brink.
[31:37] Speaker 2: Of failure just to see what would happen.
[31:39] Speaker 3: They wanted to see at what point the stress of
[31:41] Speaker 3: space causes the plant to stop producing the medicine.
[31:44] Speaker 2: Which sets up what I consider the most mind bending,
[31:48] Speaker 2: counterintuitive finding in this entire body of research.
[31:51] Speaker 3: It's quite the twist.
[31:52] Speaker 2: You take this delicate plant, you throw it in a
[31:54] Speaker 2: three D gyroscope to scramble its gravity sensors. You blast
[31:58] Speaker 2: it with temperature swings, you poison it cells with free
[32:01] Speaker 2: radicals to simulate cosmic radiation. Logically, the plant should shut down,
[32:06] Speaker 2: wither and die.
[32:07] Speaker 3: That would be the expected outcome.
[32:09] Speaker 2: At the very least, its ability to manufacture complex protein
[32:12] Speaker 2: should plummet. But the exact opposite happened. The data showed
[32:16] Speaker 2: that these extreme simulated space stressers actually resulted in an
[32:20] Speaker 2: increase in the yield of the medicine.
[32:22] Speaker 3: It is a phenomenal biological paradox. But when we unpack
[32:26] Speaker 3: the molecular mechanisms at play, the logic reveals itself beautifully.
[32:31] Speaker 2: Okay, unpack it for me. What's fascinating here is the
[32:33] Speaker 2: biology behind that increase?
[32:35] Speaker 3: Right, Yes, we have to reconsider what the medicine actually is.
[32:38] Speaker 3: The target compound, the CPMV capsid is a plant virus.
[32:43] Speaker 3: It is an active infection right on earth.
[32:46] Speaker 2: A healthy Nicochanna bin thimyana plant isn't just passively letting
[32:49] Speaker 2: the virus replicate, even with a weakened immune system. It
[32:53] Speaker 2: is still deploying resources to fight off the infection exactly.
[32:57] Speaker 3: The plant is constantly utilizing its remaining defense pathways like
[33:01] Speaker 3: salluscilic acid signaling to suppress the viral replication. It is
[33:05] Speaker 3: a biological tug of war. But what happens when you
[33:08] Speaker 3: introduce the simulated trauma of spaceflight? The microgravity, the thermal shock,
[33:13] Speaker 3: the immense oxidative damage. These are existential, immediate threats to
[33:18] Speaker 3: the plant's survival in plant panics. In biochemical terms, yes,
[33:21] Speaker 3: the plant must abruptly redirect all of its physiological resources
[33:24] Speaker 3: and energy away from fighting the virus and channel them
[33:27] Speaker 3: entirely towards surviving the environmental trauma. Prioritizing it has to
[33:31] Speaker 3: repair cellular membranes damaged by oxidative stress and try to
[33:35] Speaker 3: maintain basic homeostasis in a zero gravity environment. The antiviral
[33:40] Speaker 3: defense mechanisms are effectively abandoned.
[33:43] Speaker 2: Because fighting a virus doesn't matter if you are actively
[33:46] Speaker 2: freezing or being irradiated.
[33:48] Speaker 3: Precisely, Patrick optensteinin highlights this dynamic, noting that in traditional agriculture,
[33:54] Speaker 3: environmental stress making plants more susceptible to disease is a
[33:57] Speaker 3: catastrophic vulnerability.
[33:59] Speaker 2: A stressed is a ruined crop.
[34:01] Speaker 3: But in this highly specialized paradigm of biomanufacturing, we are
[34:05] Speaker 3: entirely inverting the paradigm. The disease is the product raw.
[34:10] Speaker 3: By subjecting the plant to the harshness of the space environment,
[34:13] Speaker 3: we are artificially suppressing its immune system, which removes the
[34:16] Speaker 3: biological breaks on viral replication.
[34:19] Speaker 2: We're literally using the hostility of space to turbo charge
[34:23] Speaker 2: the manufacturing process. The environment that physically destroys traditional chemically
[34:27] Speaker 2: synthesized pills actually forces the biological factory to work over time.
[34:31] Speaker 3: It's incredible.
[34:32] Speaker 2: The universe throws radiation at the plant and the plant's
[34:35] Speaker 2: biology is essentially hijacked to pump out even more cancer
[34:39] Speaker 2: fighting medicine. It's a master stroke of interdisciplinary engineering.
[34:43] Speaker 3: It truly is.
[34:45] Speaker 2: But it makes me wonder, if this extraction method is
[34:47] Speaker 2: so cheap, so lightweight, and so fast, why are we
[34:50] Speaker 2: only talking about astronauts. This incredible adaptability doesn't just hold
[34:54] Speaker 2: promise for the stars. This seems like it solves massive
[34:57] Speaker 2: problems on Earth right now.
[34:59] Speaker 3: Oh strial implications are arguably far more immediate and impactful
[35:04] Speaker 3: than the aerospace applications.
[35:06] Speaker 2: I do it.
[35:07] Speaker 3: This low footprint, a popplast flushing extraction method has the
[35:11] Speaker 3: potential to fundamentally revolutionize low cost pharmaceutical production in resource
[35:17] Speaker 3: limited areas right here on Earth.
[35:19] Speaker 2: Let's explore that because right now, the pharmaceutical supply chain
[35:22] Speaker 2: is highly centralized.
[35:23] Speaker 3: It is deeply centralized. The production of complex biologics, monoclonal antibodies,
[35:28] Speaker 3: and advanced immuno therapeutics is almost entirely localized and highly.
[35:31] Speaker 2: Developed nations because of the cost.
[35:33] Speaker 3: Exactly, the barrier to entry is the capital infrastructure. Building
[35:37] Speaker 3: a sterile facility with massive steel bioreactors, homogenization centrifuges, and
[35:43] Speaker 3: clean rooms costs hundreds of millions of dollars. Developing nations
[35:48] Speaker 3: or rural resource limited areas simply cannot build these facilities.
[35:52] Speaker 2: They are entirely reliant on importing the finished drugs, and
[35:56] Speaker 2: that requires a perfect, uninterrupted logistical chain.
[36:00] Speaker 3: The cold chain infrastructure.
[36:02] Speaker 2: Right, if you are trying to get complex aminotherapeutics to
[36:05] Speaker 2: a clinic in a remote region, the drug must be
[36:08] Speaker 2: kept at a specific temperature from the factory in Europe
[36:11] Speaker 2: all the way to the rural clinic.
[36:12] Speaker 3: And it's so fragile.
[36:13] Speaker 2: If a refrigerated truck breaks down or a local power
[36:16] Speaker 2: grid fails and the clinic's fridge loses power for a day,
[36:20] Speaker 2: the medicine degrades, just like it does in space.
[36:22] Speaker 3: The UC San Diego methodology completely bypasses that fragile supply chain.
[36:27] Speaker 3: The research proposes a decentralized model of biomanufacturing.
[36:31] Speaker 2: Do they make it on site?
[36:32] Speaker 3: Yes, A rural clinic doesn't need a multimillion dollar clean room.
[36:35] Speaker 3: They need a basic greenhouse structure. They need packets of
[36:38] Speaker 3: specific engineered.
[36:39] Speaker 2: Seeds an extraction kit.
[36:41] Speaker 3: Right, they just need a basic extraction kit, a vacuum chamber,
[36:45] Speaker 3: some buffer solution, and a small table pop centrifuge.
[36:49] Speaker 2: The entire pharmaceutical manufacturing plant is reduced to a tabletop
[36:53] Speaker 2: kit that doesn't rely on complex chemical precursors or heavy industry.
[36:58] Speaker 2: Local agricultural techniicians could cultivate the plants and when a
[37:02] Speaker 2: specific biologic is needed, they perform the vacuum extraction right
[37:06] Speaker 2: there at the clinic.
[37:07] Speaker 3: It shifts the power of advanced medicine production back to
[37:10] Speaker 3: the local community using the most ubiquitous accessible technology in
[37:14] Speaker 3: human history, agriculture.
[37:16] Speaker 2: It is a profound shift toward global health equity. However,
[37:20] Speaker 2: while the terrestrial groundwork is being laid, the engineering team
[37:23] Speaker 2: is still aggressively pursuing the orbital flight tests.
[37:26] Speaker 3: Of course, that's still the main goal.
[37:28] Speaker 2: The simulations with the random positioning machines provided vital data,
[37:32] Speaker 2: but simulations have limits. The next mandatory step is launching
[37:36] Speaker 2: the system into actual low Earth.
[37:37] Speaker 3: Orbit, because they need to observe how the fluid dynamics
[37:41] Speaker 3: of the vacuum infiltration actually perform. When capillary action and
[37:44] Speaker 3: service tension are the only forces moving the water inside
[37:47] Speaker 3: the leaf completely free of Earth's gravity.
[37:49] Speaker 2: That is the biological validation. But before they can even
[37:53] Speaker 2: perform the extraction in orbit, they face a brutal mechanical
[37:56] Speaker 2: reality they're currently partnering with a rock a propulsion laboratory
[38:01] Speaker 2: to subject the seeds to an entirely different class of stress.
[38:04] Speaker 3: Testing launch survival.
[38:06] Speaker 2: Yes, you can have the perfect greenhouse designed, but if
[38:09] Speaker 2: the seeds get scrambled on lift off, the whole system fails.
[38:13] Speaker 2: A rocket launch is not a gentle elevator ride to space.
[38:16] Speaker 3: No it is not.
[38:17] Speaker 2: It is a violently energetic, acoustically deafening, physically punishing event.
[38:22] Speaker 2: The payload is subjected to crushing g forces and intense
[38:25] Speaker 2: high frequency acoustic vibrations for the rocket engines, the engineering
[38:29] Speaker 2: team needs to understand exactly how those sheer kinetic forces
[38:32] Speaker 2: impact the structural integrity of the seed.
[38:34] Speaker 3: It's something you might not even think about at first.
[38:36] Speaker 3: A seed feels hard like a little pebble, but internally
[38:40] Speaker 3: it is a delicate, suspended biological embryo. Right if you
[38:44] Speaker 3: vibrate that embryo violently enough, do you shatter the internal
[38:48] Speaker 3: cellular structures? Do you scramble the genetic material needed to
[38:51] Speaker 3: start the process.
[38:52] Speaker 2: You could have the perfect space greenhouse, the most elegant
[38:55] Speaker 2: vacuum extraction protocol, and the smartest botanists on board, but
[39:00] Speaker 2: if the physical violence of liftoff scrambles the DNA inside
[39:03] Speaker 2: the seed packet. The mission fails before it even breaches
[39:06] Speaker 2: the atmosphere.
[39:07] Speaker 3: It is the ultimate mechanical bottleneck right now, Ensuring that
[39:10] Speaker 3: the biological blueprints can survive the kinetic fury of a
[39:13] Speaker 3: launch vehicle is the immediate hurdle the team is working
[39:16] Speaker 3: to clear.
[39:17] Speaker 2: The arc of this problem is just staggering to me.
[39:20] Speaker 2: We started with the fatal flaw of expiring drugs on
[39:23] Speaker 2: a Mars mission, an astronaut staring at a locker full
[39:26] Speaker 2: of expired, chemically degraded pills and.
[39:29] Speaker 3: A timeline that doesn't forgive right.
[39:31] Speaker 2: And the solution wasn't found in thicker lead shielding or
[39:34] Speaker 2: more complex chemistry. The solution was found by utilizing the
[39:37] Speaker 2: natural architecture of plant leaves.
[39:39] Speaker 3: It's beautiful really.
[39:40] Speaker 2: By mapping the empty spaces of the apoplast, engineers figured
[39:44] Speaker 2: out how to gently wring out a living plant like
[39:46] Speaker 2: a sponge, extracting a complex virus that just happens to
[39:50] Speaker 2: train the mammalian immune system to hunt down cancer cells.
[39:54] Speaker 3: We've observed a beautiful convergence of disciplines here trading the
[39:58] Speaker 3: heavy steel industry of t bioprocessing for the elegant efficiency
[40:02] Speaker 3: of soil seeds, vacuum pressure, and a gentle centrifuge.
[40:07] Speaker 2: It's a complete rething.
[40:08] Speaker 3: And the most poetic aspect is how we are weaponizing
[40:11] Speaker 3: the stress of space to produce life saving cancer therapeutics.
[40:15] Speaker 3: The very microgravity and radiation that destroys our synthetic drugs
[40:19] Speaker 3: forces the plant to lower its natural defenses, allowing us
[40:23] Speaker 3: to harvest medicine at an exponentially faster rate. It is
[40:27] Speaker 3: turning the void's hostility into a manufacturing asset.
[40:30] Speaker 2: It fundamentally changes how we view life support. It turns
[40:33] Speaker 2: a tray of leafy greens recycling air in the corner
[40:36] Speaker 2: of a habitat into the most advanced self repairing pharmacy
[40:40] Speaker 2: in the Solar system.
[40:40] Speaker 3: It absolutely does.
[40:41] Speaker 2: But as we wrap up exploring how a plant's biology
[40:44] Speaker 2: adapts to the stress of microgravity leaves me with one final,
[40:48] Speaker 2: very strange thought.
[40:49] Speaker 3: Oh, what's that?
[40:50] Speaker 2: We've just discussed how the plant alters its physiological responses
[40:54] Speaker 2: under the continuous trauma of space. What happens over time?
[40:57] Speaker 3: Like long term?
[40:58] Speaker 2: Yeah, we establish a colony on Mars and these plants
[41:02] Speaker 2: adapt generation after generation to the continuous stressors of off
[41:06] Speaker 2: world agriculture. What happens to the biological nature of the
[41:10] Speaker 2: medicines they produce? Oh wow? Will the pharmaceuticals grown by
[41:14] Speaker 2: Martian colonists fifty years from now evolve to be uniquely extraterrestrial?
[41:19] Speaker 2: Will the lack of Earth's gravity fundamentally alter the protein
[41:22] Speaker 2: folding or the viral capsids in ways we can't even predict,
[41:26] Speaker 2: potentially creating completely distinct biological cures that we could never
[41:30] Speaker 2: replicate here on Earth.
[41:31] Speaker 3: That is a staggering thought.
[41:33] Speaker 2: It's wild to ponder. I want to thank you so
[41:35] Speaker 2: much for joining us for this incredibly deep conversation into
[41:38] Speaker 2: the future of biomanufacturing. To everyone listening, keep looking up,
[41:41] Speaker 2: keep questioning the mechanics of the universe around you, and
[41:44] Speaker 2: we'll see you next time.

Shows are listed from Apple Podcasts' charts and directory, and Podcast Index where it is used. Every show and episode belongs to its publisher and plays from the publisher's own feed; this site hosts none of them.
